Kura Oncology (KURA) Enterprise Value (QoQ) (2010 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Kura Oncology | 801.92 Mn | 801.92 Mn | 18.00 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 12.95% |
| Dec 31, 2025 | -21.39% |
| Sep 30, 2025 | 12.85% |
| Jun 30, 2025 | 4.17% |
| Mar 31, 2025 | 9.51% |
| Dec 31, 2024 | -59.76% |
| Sep 30, 2024 | 7.37% |
| Jun 30, 2024 | 6.75% |
| Mar 31, 2024 | -24.33% |
| Dec 31, 2023 | 6.33% |
| Sep 30, 2023 | 5.11% |
| Jun 30, 2023 | -17.51% |
| Mar 31, 2023 | 7.33% |
| Dec 31, 2022 | -2.39% |
| Sep 30, 2022 | 4.99% |
| Jun 30, 2022 | 6.21% |
| Mar 31, 2022 | 7.31% |
| Dec 31, 2021 | 4.69% |
| Sep 30, 2021 | 4.24% |
| Jun 30, 2021 | 6.02% |
| Mar 31, 2021 | 4.65% |
| Dec 31, 2020 | -94.62% |
| Sep 30, 2020 | 3.97% |
| Jun 30, 2020 | -56.21% |
| Mar 31, 2020 | 8.42% |
| Dec 31, 2019 | 5.29% |
| Sep 30, 2019 | 4.32% |
| Jun 30, 2019 | -57.93% |
| Mar 31, 2019 | 7.52% |
| Dec 31, 2018 | 4.50% |
| Sep 30, 2018 | -48.88% |
| Jun 30, 2018 | 8.91% |
| Mar 31, 2018 | -48.37% |
| Dec 31, 2017 | 7.60% |
| Sep 30, 2017 | -89.33% |
| Jun 30, 2017 | 9.99% |
| Mar 31, 2017 | 12.74% |
| Dec 31, 2016 | 9.09% |
| Sep 30, 2016 | 6.89% |
| Jun 30, 2016 | -7.86% |
| Mar 31, 2016 | 13.40% |
| Dec 31, 2015 | -107.96% |
| Sep 30, 2015 | 10.23% |
| Jun 30, 2015 | 14.26% |
| Mar 31, 2015 | -4,666.10% |
| Dec 31, 2014 | -1,270.73% |
| Sep 30, 2014 | -1,567.34% |
| Jun 30, 2014 | 20.27% |
| Mar 31, 2014 | 6.09% |
| Dec 31, 2013 | 37.92% |
| Sep 30, 2013 | 43.44% |
| Jun 30, 2013 | -544.78% |
| Mar 31, 2013 | 39.59% |
| Dec 31, 2012 | 14.04% |
| Sep 30, 2012 | 41.08% |
| Jun 30, 2012 | 60.07% |
| Mar 31, 2012 | -462.63% |
| Dec 31, 2011 | 31.44% |
| Sep 30, 2011 | 33.50% |
| Jun 30, 2011 | -119.31% |
| Mar 31, 2011 | 84.31% |
| Dec 31, 2010 | -1,093.35% |